Orion Genomics

Executive Summary

Orion Genomics is a private U.S. company headquartered in St. Louis, Missouri, specializing in genetics, genomics, and diagnostics. Founded in 2000, the company leverages over 100 patents and proprietary technologies to address challenges in agriculture and human health. Its dual focus on research and clinical applications positions it to support partners globally in feeding, fueling, and healing. With a strong leadership team and advisory boards, Orion Genomics is uniquely positioned to drive innovation in precision agriculture and molecular diagnostics. The company's extensive patent portfolio and strategic collaborations provide a competitive edge in the rapidly evolving genomics landscape.

Upcoming Catalysts (preview)

• Q3 2026Announcement of new agricultural partnership or licensing deal70% success
• Q4 2026Publication of clinical validation data for a diagnostic test60% success
• Q2 2026Grant or expansion of a key patent in epigenetics or methylation technology80% success